KRP-105 is a selective agonist of peroxisome proliferator-activated receptor alpha (PPARα), exhibiting an effective concentration (EC50) of 8 nM. This compound has demonstrated the ability to significantly lower serum levels of triglycerides, total cholesterol, and non-high-density lipoprotein cholesterol. KRP-105 is suitable for research applications focused on metabolic diseases, particularly dyslipidemia.
KRP-105 is a selective agonist of peroxisome proliferator-activated receptor alpha (PPARα), exhibiting an effective concentration (EC50) of 8 nM. This compound has demonstrated the ability to significantly lower serum levels of triglycerides, total cholesterol, and non-high-density lipoprotein cholesterol. KRP-105 is suitable for research applications focused on metabolic diseases, particularly dyslipidemia.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
